{"id":65535,"date":"2025-01-18T10:49:18","date_gmt":"2025-01-18T10:49:18","guid":{"rendered":"https:\/\/medsbase.com\/?post_type=product&#038;p=65535"},"modified":"2026-04-30T10:23:28","modified_gmt":"2026-04-30T10:23:28","slug":"restfine","status":"publish","type":"product","link":"https:\/\/medsbase.com\/nb\/product\/restfine\/","title":{"rendered":"Restfine"},"content":{"rendered":"<div class=\"medsbase-tldr-answer\" style=\"background:#fff8e1; border-left:4px solid #f5a623; padding:14px 18px; margin:0 0 18px 0;\">\n<h3 style=\"margin-top:0;\"><strong>Kort svar<\/strong><\/h3>\n<p><strong>Restfine<\/strong> inneholder <strong>melatonin 10 mg<\/strong> \u2014 a high-dose formulation of the body&#8217;s natural sleep-onset hormone. The 10 mg strength is best suited to <strong>delayed sleep-phase disorder, severe shift work, age over 55<\/strong>, or patients who haven&#8217;t responded to lower doses. For typical adult insomnia, clinical evidence supports starting at 1\u20133 mg taken 30\u201360 minutes before bedtime \u2014 higher doses do not consistently improve outcomes and may cause more morning grogginess and vivid dreams.<\/p>\n<p><strong>Start:<\/strong> 30\u201360 minutter. <strong>Indikasjon:<\/strong> short-term insomnia, jet lag, delayed sleep-phase disorder, shift work, blind non-24-hour sleep-wake disorder. <strong>Ikke egnet for:<\/strong> chronic insomnia (CBT-I is first-line), pregnancy or breastfeeding without specialist input, autoimmune disease without specialist supervision.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f4f6f8; border-radius:6px; padding:14px 18px; margin:18px 0; display:flex; flex-wrap:wrap; gap:18px; font-size:14px;\">\n<span>\u2705 <strong>WHO-GMP sertifisert<\/strong> produsent<\/span><br \/>\n<span>\ud83d\udce6 Diskret emballasje<\/span><br \/>\n<span>\ud83c\udf0d Verdensomspennende levering<\/span><br \/>\n<span>\u2b50 <a href=\"https:\/\/medsbase.com\/nb\/reviews\/\">1,400+ kundeanmeldelser<\/a><\/span>\n<\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 Hver ordre er dekket av v\u00e5r <a href=\"https:\/\/medsbase.com\/nb\/medsbase-re-shipment-assurance-policy\/\"><strong>Reshipment Assurance Policy<\/strong><\/a> \u2014 hvis pakken din ikke ankommer innen 20 virkedager, sender vi ny.<\/p>\n<h3>Hvorfor bestille fra MedsBase<\/h3>\n<ul>\n<li><strong>WHO-GMP-sertifisert produsent<\/strong> \u2014 kvalitetskontrollerte ferdige tabletter, sporbar batch.<\/li>\n<li><strong>Diskr\u00e9 emballasje<\/strong> \u2014 n\u00f8ytral konvolutt, ingen medisin- eller apotektekst p\u00e5 utsiden.<\/li>\n<li><strong>Reshipment Assurance<\/strong> \u2014 alle bestillinger dekket (se vilk\u00e5r i policy).<\/li>\n<li><strong>Verdensomspennende levering<\/strong> med flere fraktalternativer.<\/li>\n<li><strong>1,400+ kundeanmeldelser<\/strong> over 8 \u00e5rs handel.<\/li>\n<\/ul>\n<div style=\"background:#fff8e1; border-left:4px solid #f5a623; padding:14px 18px; margin:18px 0;\">\n<h3 style=\"margin-top:0;\">Important \u2014 high-dose formulation<\/h3>\n<p>Restfine is <strong>10 mg melatonin<\/strong>. Endogenous melatonin peaks at roughly 60\u201370 picograms per millilitre overnight; a single 10 mg dose produces serum levels several hundred times physiological. <strong>For typical adult insomnia, 0.5\u20133 mg is as effective as 5\u201310 mg in head-to-head trials<\/strong> (Brzezinski 2005 meta-analysis; Buscemi 2005 systematic review for AHRQ) and is associated with less next-morning grogginess and fewer vivid dreams.<\/p>\n<p>Reasonable indications for staying at 10 mg:<\/p>\n<ul>\n<li><strong>Forsinket s\u00f8vnfasesyndrom<\/strong> (DSPD) where lower doses gave inadequate phase-shift in a clinical trial.<\/li>\n<li><strong>Age over 55<\/strong> with measured low endogenous melatonin and inadequate response to 2 mg prolonged-release formulations.<\/li>\n<li><strong>Severe shift work<\/strong> requiring deep daytime sleep.<\/li>\n<li><strong>Tumour-related sleep disturbance<\/strong> where higher doses are sometimes used under specialist supervision.<\/li>\n<\/ul>\n<p>If you are using melatonin for typical insomnia and are new to it, <strong>quarter or half the tablet<\/strong> to start at 2.5\u20135 mg and only go higher if needed. Meloset (3 mg, Sun Pharma) is our lower-dose option.<\/p>\n<\/div>\n<h3>Hvordan melatonin fungerer<\/h3>\n<p>Melatonin er et hormon som utskilles av epifysen som svar p\u00e5 m\u00f8rke. Det binder seg til MT1- og MT2-reseptorer i nucleus suprachiasmaticus (SCN) \u2013 den prim\u00e6re sirkadiske rytmegiveren i hypothalamus. Aktivering av MT1 reduserer v\u00e5kenhetsdriv (s\u00f8vninnsettelse), mens aktivering av MT2 forskyver den sirkadiske klokken. I motsetning til GABA-A-agonister (Z-preparater, benzodiazepiner), for\u00e5rsaker ikke melatonin generell CNS-depresjon, hemmer ikke minnekonsolidering, gir ikke fysisk avhengighet, og p\u00e5virker ikke kognitiv ytelse neste dag ved standarddoser.<\/p>\n<p>Faseforskyvningsrollen er grunnen til at tidspunktet har betydning. Melatonin tatt ved leggetid fremskynder s\u00f8vninnsettelse (hjelper med \u00e5 sovne). Melatonin tatt p\u00e5 ettermiddagen fremskynder hele den sirkadiske fasen (hjelper ved forsinket s\u00f8vnfasesyndrom og jetlag ved \u00f8stlig reiseretning). Tatt tidlig om morgenen, forsinker det fasen (hjelper ved jetlag ved vestlig reiseretning og fremskutt s\u00f8vnfasesyndrom).<\/p>\n<h3>Dosering etter indikasjon<\/h3>\n<table style=\"width:100%; border-collapse:collapse; margin:12px 0; font-size:14px;\">\n<thead>\n<tr style=\"background:#2c7cb0; color:#fff;\">\n<th style=\"padding:8px; text-align:left;\">Indikasjon<\/th>\n<th style=\"padding:8px;\">Dose<\/th>\n<th style=\"padding:8px;\">Tidsramme<\/th>\n<th style=\"padding:8px;\">Varighet<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding:8px;\">Short-term insomnia (adults &lt; 55)<\/td>\n<td style=\"padding:8px; text-align:center;\">1\u20133 mg (start with quarter or half tablet)<\/td>\n<td style=\"padding:8px;\">30\u201360 min f\u00f8r leggetid<\/td>\n<td style=\"padding:8px;\">1\u20132 uker<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:8px;\">S\u00f8vnl\u00f8shet hos personer over 55 \u00e5r<\/td>\n<td style=\"padding:8px; text-align:center;\">2 mg PR or 5\u201310 mg IR<\/td>\n<td style=\"padding:8px;\">1\u20132 hours before bed<\/td>\n<td style=\"padding:8px;\">opptil 13 uker (NICE)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:8px;\">Forsinket s\u00f8vnfasesyndrom<\/td>\n<td style=\"padding:8px; text-align:center;\">0.5\u20135 mg (titrate)<\/td>\n<td style=\"padding:8px;\">4\u20136 timer f\u00f8r \u00f8nsket s\u00f8vntidspunkt<\/td>\n<td style=\"padding:8px;\">spesialistledet<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:8px;\">Jetlag mot \u00f8st (\u2265 5 tidssoner)<\/td>\n<td style=\"padding:8px; text-align:center;\">2\u20135 mg<\/td>\n<td style=\"padding:8px;\">lokal sengetid p\u00e5 destinasjonen, 2\u20134 netter<\/td>\n<td style=\"padding:8px;\">til tilpasset<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:8px;\">Skiftarbeidss\u00f8vnforstyrrelse<\/td>\n<td style=\"padding:8px; text-align:center;\">1\u201310 mg<\/td>\n<td style=\"padding:8px;\">f\u00f8r daglig s\u00f8vnperiode<\/td>\n<td style=\"padding:8px;\">mens du er p\u00e5 vakt<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:8px;\">Non-24-hour sleep-wake (blind patients)<\/td>\n<td style=\"padding:8px; text-align:center;\">0.5\u201310 mg<\/td>\n<td style=\"padding:8px;\">fixed clock time daily<\/td>\n<td style=\"padding:8px;\">indefinite, specialist-led<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><em>PR = prolonged-release. IR = immediate-release. Restfine is an immediate-release tablet.<\/em><\/p>\n<h3>Bivirkninger<\/h3>\n<p><strong>Vanlige (vanligvis milde og selvbegrensende):<\/strong> drowsiness or grogginess on waking, headache, mild dizziness, nausea, vivid dreams. Vivid dreams are dose-related \u2014 stepping down from 10 mg to 3 mg usually resolves them. Daytime sleepiness suggests the dose is too high or taken too late.<\/p>\n<p><strong>Mindre vanlige:<\/strong> low mood transient (especially in patients with seasonal affective tendencies), reduced libido, mild blood-pressure changes (both directions reported), gastrointestinal upset, irritability, joint discomfort.<\/p>\n<p><strong>Sjeldne, men viktige:<\/strong> seizures (lower threshold reported in patients with epilepsy \u2014 caution and specialist input), allergic skin reactions, autoimmune flare in patients with rheumatoid arthritis or lupus.<\/p>\n<h3>Legemiddelinteraksjoner<\/h3>\n<table style=\"width:100%; border-collapse:collapse; margin:12px 0; font-size:14px;\">\n<thead>\n<tr style=\"background:#2c7cb0; color:#fff;\">\n<th style=\"padding:8px; text-align:left;\">Legemiddelklasse<\/th>\n<th style=\"padding:8px;\">Interaksjon<\/th>\n<th style=\"padding:8px;\">Handling<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding:8px;\">Fluvoxamin (SSRI)<\/td>\n<td style=\"padding:8px;\">CYP1A2-hemming \u00f8ker melatoniniv\u00e5ene 17 ganger<\/td>\n<td style=\"padding:8px;\">avoid combination \u2014 substitute another SSRI<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:8px;\">Warfarin<\/td>\n<td style=\"padding:8px;\">tilfeller av \u00f8kt INR<\/td>\n<td style=\"padding:8px;\">overv\u00e5k INR ved oppstart eller avslutning<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:8px;\">Diabetes medication (insulin, sulfonylureas)<\/td>\n<td style=\"padding:8px;\">melatonin reduserer insulinutsondringen om natten<\/td>\n<td style=\"padding:8px;\">monitor fasting glucose; specialist input in T1DM<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:8px;\">Antihypertensiva<\/td>\n<td style=\"padding:8px;\">may potentiate effect of nifedipine; may raise BP with some agents<\/td>\n<td style=\"padding:8px;\">monitor BP at start of treatment<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:8px;\">Immunosuppressants (ciclosporin, methotrexate)<\/td>\n<td style=\"padding:8px;\">melatonin har immunstimulerende effekter<\/td>\n<td style=\"padding:8px;\">avoid in solid-organ transplant or active autoimmune disease<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:8px;\">Kombinert oralt prevensjonsmiddel<\/td>\n<td style=\"padding:8px;\">CYP1A2 inhibition raises melatonin levels<\/td>\n<td style=\"padding:8px;\">consider lower melatonin dose<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:8px;\">Koffein<\/td>\n<td style=\"padding:8px;\">caffeine inhibits melatonin metabolism mildly; both also CYP1A2 substrates<\/td>\n<td style=\"padding:8px;\">avoid caffeine within 6 hours of bedtime regardless<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:8px;\">Benzodiazepiner, Z-preparater, alkohol, opioider<\/td>\n<td style=\"padding:8px;\">additiv sedering<\/td>\n<td style=\"padding:8px;\">avoid combining; do not drink alcohol with melatonin<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:8px;\">Antikonvulsiva<\/td>\n<td style=\"padding:8px;\">kan senke anfallsterskelen (kasusrapporter)<\/td>\n<td style=\"padding:8px;\">spesialistvurdering ved epilepsi<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h3>Kontraindikasjoner og forsiktighetsregler<\/h3>\n<ul>\n<li><strong>Graviditet og amming<\/strong> \u2014 safety not established; avoid unless specialist-supervised.<\/li>\n<li><strong>Aktiv autoimmun sykdom<\/strong> (RA, lupus, MS, IBD) \u2014 melatonin has immunostimulant effects; specialist input required.<\/li>\n<li><strong>Fast organ transplantasjon p\u00e5 immundemping<\/strong> \u2014 unng\u00e5.<\/li>\n<li><strong>Alvorlig leversvikt<\/strong> \u2014 accumulation; reduce dose or avoid.<\/li>\n<li><strong>Epilepsi<\/strong> \u2014 case reports of lowered seizure threshold; specialist input.<\/li>\n<li><strong>Barn og ungdom under 18 \u00e5r<\/strong> \u2014 only under specialist paediatric supervision (used in autism spectrum sleep disturbance; not for typical childhood insomnia).<\/li>\n<li><strong>Driving or operating machinery<\/strong> \u2014 do not drive within 8 hours of dose, particularly in the first few nights.<\/li>\n<li><strong>Alkohol<\/strong> \u2014 avoid; potentiates sedation and blunts melatonin&#8217;s circadian effect.<\/li>\n<\/ul>\n<h3>Oppbevaring<\/h3>\n<p>Store at 15\u201330\u00b0C (room temperature) in the original blister, away from direct sunlight, heat, and humidity. Do not refrigerate. Keep out of reach of children. Do not use after the expiry date printed on the strip.<\/p>\n<h2 id=\"faqs\">Vanlige sp\u00f8rsm\u00e5l<\/h2>\n<h3>Is 10 mg melatonin too high for typical insomnia?<\/h3>\n<p>For most adults under 55 with typical short-term insomnia, yes \u2014 0.5\u20133 mg has the same sleep-onset effect with less morning grogginess and fewer vivid dreams. Use 10 mg if lower doses haven&#8217;t worked, for delayed sleep-phase disorder under specialist input, for severe shift work, or for age 55+ with confirmed low endogenous melatonin.<\/p>\n<h3>Can I split a Restfine tablet in half?<\/h3>\n<p>Yes. Restfine is an immediate-release uncoated tablet \u2014 splitting in half gives ~5 mg, in quarters gives ~2.5 mg. Use a tablet splitter for accuracy. Do not crush or chew if you find the taste unpleasant \u2014 it is bitter.<\/p>\n<h3>How long does melatonin take to work?<\/h3>\n<p>30\u201360 minutes for sleep onset. Peak plasma concentration is roughly 60 minutes after an oral immediate-release dose; half-life is 30\u201350 minutes. The phase-shifting effect on circadian rhythm builds over several nights.<\/p>\n<h3>Is melatonin habit-forming?<\/h3>\n<p>No. Melatonin does not cause physical dependence, tolerance, or rebound insomnia in standard short-term use. This is its main advantage over benzodiazepines and Z-drugs (zolpidem, zopiclone). Long-term use (more than 3 months) has less evidence and should be reviewed with your doctor periodically.<\/p>\n<h3>Can I take melatonin with alcohol?<\/h3>\n<p>No. Alcohol fragments sleep architecture, suppresses REM, and disrupts the circadian rhythm \u2014 the opposite of what melatonin is trying to do. The combination produces additive next-day grogginess without improving sleep quality.<\/p>\n<h3>Will melatonin help with chronic insomnia (more than 3 months)?<\/h3>\n<p>Modestly at best. The most effective long-term treatment for chronic insomnia is cognitive-behavioural therapy for insomnia (CBT-I), not pharmacotherapy. Online programmes are widely available. If insomnia persists despite CBT-I and good sleep hygiene, sleep-medicine review can identify contributors (sleep apnoea, restless legs, depression, perimenopause).<\/p>\n<h3>Does melatonin work for jet lag?<\/h3>\n<p>Yes \u2014 particularly for eastward travel across 5+ time zones. Take 2\u20135 mg at local bedtime at the destination for 2\u20134 nights. Westward travel responds less to melatonin (the body adapts more easily to delaying the clock than advancing it). Combine with bright daylight exposure at the destination.<\/p>\n<h3>Can I take melatonin for shift work?<\/h3>\n<p>Yes \u2014 melatonin before the daytime sleep period helps shift workers consolidate sleep. The challenge is finding the right time: it is roughly the start of your &ldquo;biological night&rdquo;, which depends on your shift pattern. Avoid taking before driving home from a night shift \u2014 wait until you are at home and ready for bed.<\/p>\n<h3>Does melatonin interact with my contraceptive pill?<\/h3>\n<p>Combined oral contraceptives raise endogenous melatonin levels by about 20% via CYP1A2 inhibition. This usually does not require a melatonin dose change, but if you are sensitive to morning grogginess on melatonin, consider stepping down from 10 mg to 3 mg.<\/p>\n<h3>Can melatonin trigger an autoimmune flare?<\/h3>\n<p>It can. Melatonin has immunostimulant effects \u2014 useful in some research settings but a problem in active rheumatoid arthritis, lupus, multiple sclerosis, and inflammatory bowel disease. Get specialist input before using melatonin if you have any active autoimmune condition.<\/p>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3>Andre s\u00f8vnhjelpemidler og hypnotika<\/h3>\n<p>Medikamentene nedenfor behandler samme indikasjon via forskjellige mekanismer. Valg avhenger av alder, samtidig depresjon eller angst, og hvor kortvarig eller langsiktig bruken vil v\u00e6re.<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/nb\/meloset\/\"><strong>Meloset (Melatonin 3 mg)<\/strong><\/a> \u2014 standard-dose melatonin (Sun Pharma).<\/li>\n<li><a href=\"https:\/\/medsbase.com\/nb\/trazalon\/\"><strong>Trazalon (Trazodon 50 mg)<\/strong><\/a> \u2014 lav dose hypnotikum brukt utenfor godkjent indikasjon \u2014 det mest foreskrevne s\u00f8vnhjelpemiddelet utenfor godkjent indikasjon globalt.<\/li>\n<li><a href=\"https:\/\/medsbase.com\/nb\/mirzacan\/\"><strong>Mirzacan (Mirtazapin 30 mg)<\/strong><\/a> \u2014 sedativ tetracyclisk antidepressiv \u2014 nyttig n\u00e5r depresjon og s\u00f8vnl\u00f8shet opptrer samtidig.<\/li>\n<li><a href=\"https:\/\/medsbase.com\/nb\/spectra\/\"><strong>Spectra (Doxepin)<\/strong><\/a> \u2014 lav dose doxepin (3\u20136 mg) for s\u00f8vnvedlikehold hos eldre.<\/li>\n<li><a href=\"https:\/\/medsbase.com\/nb\/atarax\/\"><strong>Atarax (Hydroksysin 25 mg)<\/strong><\/a> \u2014 sedativ antihistamin for kortvarig angstrelatert s\u00f8vnl\u00f8shet.<\/li>\n<\/ul>\n<h3>Medisinsk ansvarsfraskrivelse<\/h3>\n<p>Denne siden er til informasjonsform\u00e5l og erstatter ikke personlig medisinsk r\u00e5dgivning. Vedvarende s\u00f8vnl\u00f8shet (mer enn 3 m\u00e5neder) b\u00f8r utredes for underliggende \u00e5rsaker \u2014 depresjon, angst, s\u00f8vnapn\u00e9, restless legs, kroniske smerter, perimenopause, hypertyreose. Kognitiv atferdsterapi for s\u00f8vnl\u00f8shet (CBT-I) er den mest effektive langsiktige intervensjonen. Snakk med helsepersonell f\u00f8r du starter, stopper eller kombinerer s\u00f8vnhjelpemidler \u2014 spesielt hvis du tar warfarin, diabetesmedisin, immundempende midler, fluvoksamin eller orale prevensjonsmidler, eller hvis du har en autoimmun tilstand. Hvis s\u00f8vnl\u00f8shet kombineres med vedvarende nedstemthet, h\u00e5pl\u00f8shet eller tanker om selvskade, kontakt en kriselinje (US 988, UK Samaritans 116 123, eller <a href=\"https:\/\/findahelpline.com\/\" rel=\"nofollow noopener\" target=\"_blank\">findahelpline.com<\/a>).<\/p>","protected":false},"excerpt":{"rendered":"<p>Restfine (melatonin 10 mg) \u2014 high-dose pineal-hormone tablet for delayed sleep-phase disorder, severe shift work, and age 55+ insomnia. Non-addictive, no rebound; lower-dose Meloset 3 mg available for typical adult insomnia.<\/p>","protected":false},"featured_media":65536,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[3887],"product_tag":[3888,5346],"class_list":{"0":"post-65535","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-sleeping-tablets","7":"product_tag-melatonin","8":"product_tag-restfine","10":"first","11":"instock","12":"shipping-taxable","13":"purchasable","14":"product-type-variable","15":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/nb\/wp-json\/wp\/v2\/product\/65535","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/nb\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/nb\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/nb\/wp-json\/wp\/v2\/comments?post=65535"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/nb\/wp-json\/wp\/v2\/media\/65536"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/nb\/wp-json\/wp\/v2\/media?parent=65535"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/nb\/wp-json\/wp\/v2\/product_brand?post=65535"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/nb\/wp-json\/wp\/v2\/product_cat?post=65535"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/nb\/wp-json\/wp\/v2\/product_tag?post=65535"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}